In addition, tumor-infiltrating MDSCs have been shown to produce ONOO–, which nitrates tyrosine residues in the T cell receptor-CD8 complex, thus disrupting the binding of specific peptide-major histocompatibility complex dimers to CD8+ T cells [203]. This evidence concerns the gene CD8A and neoplasm.